Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

MaxCyte (MXCT) Regulatory News

Date Source Headline
5th Feb 2020 7:00 am RNS MaxCyte to Present at BIO CEO & Investor Conf
24th Jan 2020 4:31 pm RNS Grant Of Options
22nd Jan 2020 5:15 pm RNS Holding(s) in Company
22nd Jan 2020 5:11 pm RNS Holding(s) in Company
22nd Jan 2020 5:08 pm RNS Holding(s) in Company
20th Jan 2020 7:00 am RNS Trading Update
19th Dec 2019 7:00 am RNS New Executive Vice President and Trial Update
16th Dec 2019 5:25 pm RNS Director/PCA transaction initial notification
4th Dec 2019 7:00 am RNS Agreement with KSQ Therapeutics
21st Nov 2019 7:00 am RNS Vor Biopharma Clinical and Commercial License
14th Nov 2019 7:00 am RNS Presentation at Jefferies Healthcare Conference
7th Nov 2019 7:00 am RNS MaxCyte to Present at BIO-Europe 2019
1st Nov 2019 1:04 pm RNS Result of AGM
24th Oct 2019 7:00 am RNS MaxCyte Advances Phase I Clinical Trial
23rd Oct 2019 7:01 am RNS Presentations at Cell & Gene Therapy Congress
8th Oct 2019 7:00 am RNS Notification of AGM and Audit Declaration
7th Oct 2019 7:00 am RNS Editas Clinical and Commercial License Agreement
30th Sep 2019 7:00 am RNS Updates on CARMA Platform at Upcoming Meetings
18th Sep 2019 7:00 am RNS Results for the Six Months ended 30 June 2019
9th Sep 2019 7:00 am RNS Presentation at ICLE 2019
14th Aug 2019 7:00 am RNS Notice of Results
17th Jul 2019 7:00 am RNS Trading Update
11th Jul 2019 7:00 am RNS MaxCyte to Host Capital Markets Day Today
5th Jul 2019 4:42 pm RNS Second Price Monitoring Extn
5th Jul 2019 4:36 pm RNS Price Monitoring Extension
19th Jun 2019 7:00 am RNS Annual Report
12th Jun 2019 7:00 am RNS Appointment of Joint Corporate Broker
29th May 2019 7:00 am RNS Save the Date: Capital Markets Day
8th May 2019 4:41 pm RNS Second Price Monitoring Extn
8th May 2019 4:36 pm RNS Price Monitoring Extension
8th May 2019 7:00 am RNS Phase I Clinical Trial of MCY-M11 Progressed
1st May 2019 7:00 am RNS ASGCT Presentation on First CARMA Drug Candidate
24th Apr 2019 7:00 am RNS Final Results for Year Ended 31 December 2018
8th Apr 2019 7:00 am RNS Launch of ExPERTT Instrument Family
26th Mar 2019 7:00 am RNS Notice of Full Year Results
19th Mar 2019 5:05 pm RNS Director Dealings
5th Mar 2019 7:00 am RNS Grant of Options
1st Mar 2019 7:00 am RNS Clinical & Commercial Agreement with Kite
26th Feb 2019 5:32 pm RNS Result of Special Meeting and Issue of Equity
5th Feb 2019 4:32 pm RNS Results of Placing
FTSE 100 Latest
Value8,275.66
Change0.00